HERON THERAPEUTICS INC HERON TH (0J4V.L) Financials
0J4V.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 229.2 million | 257.0 million |
2023-06-30 | 201.2 million | 240.5 million |
2023-03-31 | 220.9 million | 232.3 million |
2022-12-31 | 251.0 million | 237.4 million |
0J4V.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -10.0 million | 6.7 million |
2023-06-30 | -27.4 million | 13.9 million |
2023-03-31 | -25.1 million | 7.9 million |
2022-12-31 | -37.9 million | 10.5 million |
0J4V.L Net Income
No data available :(
0J4V.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 77.4 million | - | - |
2023-06-30 | 33.2 million | - | - |
2023-03-31 | 60.0 million | - | - |
2022-12-31 | 84.9 million | - | - |
0J4V.L Shares Outstanding
0J4V.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 793000 | 13.6 million | 9.4 million | 12.0 million |
2023-06-30 | 278000 | 17.6 million | 10.1 million | 16.2 million |
2023-03-31 | 224000 | 13.8 million | 10.9 million | 21.2 million |
2022-12-31 | 414000 | 11.1 million | 8.7 million | 16.8 million |
0J4V.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 31.4 million | 18.2 million |
2023-06-30 | 31.8 million | 20.2 million |
2023-03-31 | 29.6 million | 16.9 million |
2022-12-31 | 30.0 million | 12.6 million |
0J4V.L
Price: $3.26
52 week price:
Earnings Per Share: -2.29 USD
P/E Ratio: -1.01
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 2.3 million